Chemoinformaics analysis of HOMOPROTOCATECHUIC-ACID
| Molecular Weight | 264.321 | nRot | 4 |
| Heavy Atom Molecular Weight | 244.161 | nRig | 10 |
| Exact Molecular Weight | 264.136 | nRing | 1 |
| Solubility: LogS | -3.472 | nHRing | 0 |
| Solubility: LogP | 2.866 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 41.5939 |
| nHD | 2 | BPOL | 21.8001 |
| QED | 0.62 |
| Synth | 3.96 |
| Natural Product Likeliness | 1.559 |
| NR-PPAR-gamma | 0.021 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.337 |
| Pgp-sub | 0.02 |
| HIA | 0.056 |
| CACO-2 | -4.572 |
| MDCK | 0.000019 |
| BBB | 0.062 |
| PPB | 0.751246 |
| VDSS | 1.186 |
| FU | 0.172688 |
| CYP1A2-inh | 0.133 |
| CYP1A2-sub | 0.125 |
| CYP2c19-inh | 0.267 |
| CYP2c19-sub | 0.718 |
| CYP2c9-inh | 0.041 |
| CYP2c9-sub | 0.124 |
| CYP2d6-inh | 0.049 |
| CYP2d6-sub | 0.116 |
| CYP3a4-inh | 0.02 |
| CYP3a4-sub | 0.211 |
| CL | 6.84 |
| T12 | 0.177 |
| hERG | 0.004 |
| Ames | 0.929 |
| ROA | 0.761 |
| SkinSen | 0.313 |
| Carcinogencity | 0.254 |
| EI | 0.345 |
| Respiratory | 0.935 |
| NR-Aromatase | 0.044 |
| Antiviral | Yes |
| Prediction | 0.855721 |